THC <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc. Acquires The Headquarters Group, Expanding Presence in Oregon and California Cannabis Markets
THC Therapeutics, Inc. has announced the acquisition of The Headquarters Group, Inc., consolidating its position in the legal cannabis industry. The transaction, valued at approximately $11 million, was completed through the issuance of 11,007 thousand shares of Series D Preferred stock. This strategic move unites THC Therapeutics with The Headquarters Group, a company with over 60 years of combined experience in genetics, cultivation, extraction, and distribution, as well as specialty real estate and nutrients for cannabis growers. The acquisition includes companies with a combined revenue of $4.8 million and is intended to maximize efficiencies and generate significant revenue through a fully integrated vertical cannabis platform.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. THC Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-25-004827), on June 27, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。